BAYLOR SCOTT AND WHITE MC AT SUNNYVA — History
CCN 670060 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$88M
Latest Revenue (FY2022)
-1.1%
Revenue CAGR (3yr)
-3.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $90M | $109M | $88M | -19.9% | -1.1% |
| Operating Expenses | $80M | $94M | $91M | -3.1% | +6.5% |
| Operating Margin | 10.4% | 14.1% | -3.9% | -127.3% | +0.0% |
| Net Income | $9M | $15M | $-3M | -121.8% | +0.0% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 19,716 | 22,574 | 16,644 | -26.3% | -8.1% |
| Medicare Day % | 29% | 21% | 22% | +3.9% | -13.7% |
| Medicaid Day % | 0% | 0% | 0% | +38.1% | +6.0% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.2% ($90M → $88M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.1%
This Hospital
+7.6%
State Avg
Latest Margin
-3.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $87M | -11.0% |
| FY2024 (proj) | $86M | -18.1% |
| FY2025 (proj) | $85M | -25.2% |